The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."
Trump, who has been looking to announce progress in fighting the virus, touted the news as a “historic breakthrough” at a White House news conference on Sunday, saying it would “dramatically expand access to this treatment.”
Trump suggested to reporters that the FDA was playing politics in its decisions regarding emergency use authorization for convalescent plasma. Trump said he didn’t want any “delays” in the decision process.
Convalescent plasma is created from blood of individuals who have recovered from the coronavirus.
Which company is monopolizing the Covid-19 cure market?
A Killer Enterprise: How One Of Big Pharma’s Most Corrupt Companies Plans To Corner The Covid-19 Cure Market
Emergent Biosolutions,One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 anthrax attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis.
Emergent Biosolutions (formerly Bioport) has a long history of corruption and political influence peppered with public health scandals and pharmaceutical profiteering. From experimental anthrax vaccines harming thousands of American soldiers, all the while sheltered and nourished through ties to various US gov agencies, to profiteering with ebola and zika vaccines as well as monopolizing nasal naloxone spray (Narcan) to profit widely off of the pharmaceutical-driven opioid epidemic (a treatment serves merely to perpetuate the epidemic that claimed around 70,000 lives in US in 2018).
Emergent’s history of corruption and profiteering has in no way prevented them from cashing in on the Covid-19 global health crisis. Now Emergent Biosolutions (EB) is cornering the market for covid19 treatment with two different blood plasma treatments,the first experimental blood plasma treatment involves pooling and concentrating blood plasma from recovered Covid-19 patients, (acquired through support from Health and Human Services,HHS) that might otherwise be used directly to save lives of the most severe cases,while the second uses plasma taken from horses that have been injected with parts of the virus.
According to media reports at the time, the vaccine would be developed as follows:
“Scientists would harvest viral antibodies from someone who has recovered from a disease such as flu or Ebola. After testing the antibodies’ ability to neutralize viruses in a petri dish, they would isolate the most effective one, determine the genes needed to make that antibody, and then encode many copies of those genes into a circular snippet of genetic material — either DNA or RNA, that the person’s body would then use as a cookbook to assemble the antibody.”
The Defense Advanced Research Projects Agency (DARPA) has since been promoting permanent gene modifications as a means of protecting U.S. troops from biological weapons and infectious disease. Why is DARPA doing this? [To] protect a soldier on the battlefield from chemical weapons and biological weapons by controlling their genome — having the genome produce proteins that would automatically protect the soldier from the inside out,” then-DARPA director Steve Walker (now with Lockheed Martin) said.
Vaccine research and development may only create devastating military power. Where is the U.S. government’s red line?
FDA expands access to plasma treatment for COVID-19
Trump, who has been looking to announce progress in fighting the virus, touted the news as a “historic breakthrough” at a White House news conference on Sunday, saying it would “dramatically expand access to this treatment.”
Trump suggested to reporters that the FDA was playing politics in its decisions regarding emergency use authorization for convalescent plasma. Trump said he didn’t want any “delays” in the decision process.
Convalescent plasma is created from blood of individuals who have recovered from the coronavirus.
Which company is monopolizing the Covid-19 cure market?
A Killer Enterprise: How One Of Big Pharma’s Most Corrupt Companies Plans To Corner The Covid-19 Cure Market
Emergent Biosolutions,One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 anthrax attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis.
Emergent Biosolutions (formerly Bioport) has a long history of corruption and political influence peppered with public health scandals and pharmaceutical profiteering. From experimental anthrax vaccines harming thousands of American soldiers, all the while sheltered and nourished through ties to various US gov agencies, to profiteering with ebola and zika vaccines as well as monopolizing nasal naloxone spray (Narcan) to profit widely off of the pharmaceutical-driven opioid epidemic (a treatment serves merely to perpetuate the epidemic that claimed around 70,000 lives in US in 2018).
Emergent’s history of corruption and profiteering has in no way prevented them from cashing in on the Covid-19 global health crisis. Now Emergent Biosolutions (EB) is cornering the market for covid19 treatment with two different blood plasma treatments,the first experimental blood plasma treatment involves pooling and concentrating blood plasma from recovered Covid-19 patients, (acquired through support from Health and Human Services,HHS) that might otherwise be used directly to save lives of the most severe cases,while the second uses plasma taken from horses that have been injected with parts of the virus.
According to media reports at the time, the vaccine would be developed as follows:
“Scientists would harvest viral antibodies from someone who has recovered from a disease such as flu or Ebola. After testing the antibodies’ ability to neutralize viruses in a petri dish, they would isolate the most effective one, determine the genes needed to make that antibody, and then encode many copies of those genes into a circular snippet of genetic material — either DNA or RNA, that the person’s body would then use as a cookbook to assemble the antibody.”
The Defense Advanced Research Projects Agency (DARPA) has since been promoting permanent gene modifications as a means of protecting U.S. troops from biological weapons and infectious disease. Why is DARPA doing this? [To] protect a soldier on the battlefield from chemical weapons and biological weapons by controlling their genome — having the genome produce proteins that would automatically protect the soldier from the inside out,” then-DARPA director Steve Walker (now with Lockheed Martin) said.
Vaccine research and development may only create devastating military power. Where is the U.S. government’s red line?
FDA expands access to plasma treatment for COVID-19
